Search results

{{r|Platelet glycoprotein GPIIb-IIIa complex}}

| pagename = Platelet aggregation inhibitors | abc = platelet aggregation inhibitors

| pagename = Platelet activation | abc = Platelet activation

{{r|Platelet}}

...nal |author=Fritz E, Ludwig H, Scheithauer W, Sinzinger H |title=Shortened platelet half-life in multiple myeloma |journal=Blood |volume=68 |issue=2 |pages=514 ...s Disease. The chronic form in adults is usually caused by antibodies to [[Platelet glycoprotein GPIIb-IIIa complex]] or Ib-IX.<ref name="isbn0-7216-0187-1"/>

.../> This leaves vasoconstriction, platelet aggregation, and thrombosis from platelet thromboxane A2 mediated by COX-1 intact.<ref name="pmid-16968830"/>

{{r|Platelet}}

{{r|Platelet}}

{{r|Platelet}}

{{r|Platelet}}

{{r|Platelet}}

...actor complex. The von Willebrand factor has receptors for [[collagen]], [[platelet]]s, and [[ristocetin]] activity as well as the immunologically distinct ant

{{r|Platelet}}

{{r|Platelet}}

...'''cangrelor''' is an [[purinergic P2Y receptor antagonist]]s that is a [[platelet aggregation inhibitor]]. ...Stone GW, Mahaffey KW, Gibson CM, Steg PG, Hamm CW et al.| title=Effect of platelet inhibition with cangrelor during PCI on ischemic events. | journal=N Engl J

{{r|Platelet}}

Nancy Sculerati has already built an extensive "Platelet" page that I didn't notice before building this "Platelets" page. There was

{{r|Platelet transfusion}}

...antagonize or impair any mechanism leading to blood [[platelet activation|platelet aggregation]], whether during the phases of activation and shape change or Inhibitors of the [[platelet glycoprotein GPIIb-IIIa complex]] (GPIs) include the [[monoclonal antibody]

{{r|Platelet}}